<?xml version="1.0" encoding="UTF-8"?>
<p id="Par42">Whole blood was sampled before the initiation of ART. CD4 cells were counted by flow cytometry at local CDCs within 12 h of sample collection. Plasma was isolated and sent under cold-chain conditions to the laboratory at NCAIDS, China CDC. RNA was extracted from 200 μl of plasma, amplified, and used to sequence the HIV 
 <italic>pol</italic> region following an in-house method [
 <xref ref-type="bibr" rid="CR23">23</xref>, 
 <xref ref-type="bibr" rid="CR24">24</xref>]. The definition of any drug resistance is defined with respect to one or more of the following drugs or drug classes: Efavirenz (EFV), Nevirapine (NVP), any NRTI, Darunavir (DRV/r), Lopinavir (LPV/r), or Atazanavir (ATV/r) [
 <xref ref-type="bibr" rid="CR11">11</xref>]. The classification “susceptible or potential low-level” indicates no drug resistance (Stanford penalty score &lt; 15) and a classification of at least low-level indicates drug resistance (Stanford penalty score ≥ 15) [
 <xref ref-type="bibr" rid="CR11">11</xref>]. PDR was evaluated using the algorithm of the Stanford HIV Drug Resistance Database (HIVDB) (
 <ext-link ext-link-type="uri" xlink:href="https://hivdb.stanford.edu/hivdb/by-sequences/" xmlns:xlink="http://www.w3.org/1999/xlink">https://hivdb.stanford.edu/hivdb/by-sequences/</ext-link>).
</p>
